Margaret Ancona sold $321k of MYGN
SVP, Chief of Staff at MYRIAD GENETICS INC. 11,538 shares at an average of $27.82, traded Aug 21, 2024, filed Aug 23, 2024.
Score components
- +15RoleOfficer
- +14Trade size$321k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.7%, 3m -44.9%, 6m -49.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001843568-24-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 21, 2024 | SOpen-market sale Common Stock | -11,538 | $27.82 | $321k | 79,366 | Aug 23, 2024 |
Related signals
Other insiders at MYRIAD GENETICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 3Weak | MYRIAD GENETICS INC | Rashmi Kumar director | $67k 15,000 shares | -8% | |
| 41Moderate | MYGNbuy MYRIAD GENETICS INC | Paul Bisaro director | $28k 7,500 shares | +8% | |
| 56Moderate | MYRIAD GENETICS INC | Samraat S. Raha President and CEO | $200k 40,000 shares | +9% | |
| 59Moderate | MYRIAD GENETICS INC | S. Louise Phanstiel director | $495k 104,507 shares | +59% | |
| 20Weak | MYRIAD GENETICS INC | Paul J Diaz President and CEO | $344k 15,000 shares | -2% | |
| 36Weak | MYRIAD GENETICS INC | Paul J Diaz President and CEO | $401k 15,000 shares | -2% | |
| 37Weak | MYRIAD GENETICS INC | Dale Muzzey Chief Scientific Officer | $55k 2,100 shares | -2% | |
| 43Moderate | MYRIAD GENETICS INC | Heinrich Dreismann director | $271k 10,000 shares | -8% | |
| 55Moderate | MYRIAD GENETICS INC | Colleen F Reitan director | $1.3M 46,012 shares | -52% | |
| 15Weak | MYRIAD GENETICS INC | Rashmi Kumar director | $210k 7,500 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.